Clinical Trial Update: The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers [NA]

View source ↗

Summary

An update on a clinical trial evaluating Fibroscan to assess liver fibrosis in patients with cardiac pacemakers; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Snippet

Sponsor: University of Saskatchewan | Conditions: Liver Cirrhosis | NA | Status: UNKNOWN